Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: Inverse relationship between affinity and duration of action of A2A agonists

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 1, 2001, Pages 209-218

  Gao, Zhenhai ^a   Li, Zhihe ^a   Baker, Stephen P ^b   Lasley, Robert D ^c   Meyer, Stephanie ^a   Elzein, Elfatih ^a   Palle, Venkata ^a   Zablocki, Jeff A ^a   Blackburn, Brent ^a   Belardinelli, Luiz ^a  

^a CV THERAPEUTICS INC   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CYCLOHEXYLMETHYLIDENEHYDRAZINOADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; BINODENOSON; CVT 3033; CYCLIC AMP; RADIOISOTOPE; REGADENOSON; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ADENOSINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; CORONARY VESSELS; CORPUS STRIATUM; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; PC12 CELLS; PHENETHYLAMINES; PURINES; PYRAZOLES; RATS; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; SWINE; TRIAZINES; TRIAZOLES; VASODILATION; VASODILATOR AGENTS;

EID: 0034967227     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. The cardiac effects of adenosine
2. Binding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranes
3. The A2A adenosine receptor mediates coronary vasodilation
4. An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells
5. Evidence of spare A1-adenosine receptors in guinea pig atrioventricular node
6. A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. Cross-talk between cyclic AMP and protein kinase C pathways
7. Purification of A1 adenosine receptor-G-protein complexes: Effects of receptor down-regulation and phosphorylation on coupling
8. Pharmacological stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470). A novel, short-acting adenosine A2A receptor agonist
9. Myocardial blood flow and myocardial uptake of (201)Tl and (99m)Tc-Sestamibi during coronary vasodilation induced by CGS-21680, a selective adenosine A(2A) receptor agonist
10. Adenosine A(2A) receptors mediate coronary microvascular dilation to adenosine: Role of nitric oxide and ATP-sensitive potassium channels
11. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity
12. Partial agonists for adenosine receptors
13. Atrioventricular nodal accommodation in isolated guinea pig hearts: Physiological significance and role of adenosine
14. Characterization of the adenosine receptor in porcine coronary arteries
15. Ligand selectivity of dog coronary adenosine receptor resembles that of adenylate cyclase stimulatory (Ra) receptors
16. Effects of adenosine A2A receptor agonist, CGS 21680, on blood pressure, cardiac index and arterial conductance in anaesthetized rats
17. Cardiovascular purinoceptors
18. The in vitro pharmacology of ZM 241385, a potent, non-xanthine, A2a selective adenosine receptor antagonist
19. A2A-adenosine receptor reserve for coronary vasodilation
20. A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig
21. Mechanism-based pharmacokinetic-pharmacodynamic modeling of antilipolytic effects of adenosine A(1) receptor agonists in rats: Prediction of tissue-dependent efficacy in vivo
22. Adenosine stress imaging
23. Myocardial perfusion imaging versus two-dimensional echocardiography: Comparative value in the diagnosis of coronary artery disease
24. Coronary vasodilation by a short acting, low affnity A2A adenosine receptor agonist in anesthetized closed chest dogs: A second generation of coronary artery pharmacologic "stressor"